S-Biomedic GmbH
S-Biomedic is a Belgium-based life science company pioneering the use of living skin bacteria for skin health, with a focus on skin microbiome modulation for cosmetic and dermatological applications.
About
S-Biomedic is at the forefront of skin microbiome research and commercialization, pioneering the use of living skin bacteria and proprietary modulation technologies to restore and maintain skin health. Their mission is to become the global leader in microbiome dermatological skincare solutions by harnessing the natural interaction between skin and its microbiome to offer innovative products addressing skin conditions such as acne, eczema, rosacea and skin aging. S-Biomedic was founded by scientists Bernhard Paetzold and Marc Güell, joined by Veronika Oudova, and has performed the first-ever skin microbiome transplantation. The company develops technologies based on beneficial strains of Cutibacterium acnes, providing both probiotics and postbiotics for the cosmetic and dermatological markets. S-Biomedic has been recognized for its scientific excellence and is now part of Beiersdorf.
Products & Services
- CutiNaturalis™ Probiotic - a unique live bacterial skincare active (Cutibacterium acnes CA-31) for restoring skin microbiome balance
- Sencyr® Living Skin Probiotics technology and skincare system for acne-prone skin
- Active ingredients based on true skin commensal Cutibacterium acnes strains (including CA-31® & CA-81® strains)
- Novel pro- and postbiotics for skin
- Living Skin Probiotic and Postbiotic ingredients for cosmetic and dermatological applications
- Technology platform for skin microbiome modulation
Use Cases & Case Studies
- CutiModulis™ probiotic product for acne-prone skin (demonstrated efficacy in clinical study)
- Use of CutiNaturalis™ for restoration of facial skin microbiome after environmental stressors, harsh compounds, or certain cosmetic usage
- Clinical study demonstrating significant improvement in acne lesion count and skin redness reduction
Partnerships & Collaborations
- Beiersdorf (acquirer, business partner and investor since 2018)
- DSM (Royal DSM) - commercial and research agreement for probiotic skincare
- Johnson & Johnson Innovation JLABS (incubator residency)
- European Union’s Horizon 2020 programme
- Flanders Innovation & Entrepreneurship (VLAIO)
- Verve Ventures
- CG Health Ventures
- Start it @KBC
- Flanders.bio
- Pharmabiotic Research Institute (PRI)
Awards & Recognition
- Top 10 Young European Biotech Entrepreneurs (labiotech.eu, for CEO)
- Winner South Summit (2015)
- Successful completion of prestigious financing with European Innovation Council Fund